KFY:NYSEKorn Ferry Analysis
Data as of 2026-05-19 - not real-time
$65.68
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock is trading near a key support zone with the 20‑day moving average just above price and the 50‑day average providing a modest cushion, while the 200‑day average remains higher, suggesting a mixed short‑term bias. Momentum indicators sit around the neutral midpoint, with the RSI indicating neither overbought nor oversold conditions and the MACD histogram turning negative, hinting at bearish pressure. Valuation perspective: The price‑to‑earnings multiple is well below the industry average, and a discounted cash‑flow model implies a fair value substantially higher than today’s level, delivering an attractive upside potential. The dividend yield is comfortably above three percent with a payout ratio well under fifty percent, supporting dividend sustainability.
Fundamental strengths: Revenue is growing at a healthy pace, margins are solid for a consulting business, and cash flow generation comfortably covers debt obligations, leaving ample room for reinvestment or shareholder returns. The balance sheet is strong, with cash exceeding debt, and return metrics indicate efficient capital use. Risk considerations: Volatility is moderate and beta is below market, while sector‑specific risks are limited and the company’s U.S. focus keeps geographic and currency exposures low. Overall, the combination of undervaluation, robust fundamentals, and a reliable dividend makes the stock compelling for investors willing to navigate short‑term technical headwinds.
Fundamental strengths: Revenue is growing at a healthy pace, margins are solid for a consulting business, and cash flow generation comfortably covers debt obligations, leaving ample room for reinvestment or shareholder returns. The balance sheet is strong, with cash exceeding debt, and return metrics indicate efficient capital use. Risk considerations: Volatility is moderate and beta is below market, while sector‑specific risks are limited and the company’s U.S. focus keeps geographic and currency exposures low. Overall, the combination of undervaluation, robust fundamentals, and a reliable dividend makes the stock compelling for investors willing to navigate short‑term technical headwinds.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price hovering near technical support
- bearish MACD momentum
- attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- significant valuation gap to fair value
- steady earnings growth and margin expansion
- sustainable dividend supporting total return
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- secular demand for talent and organizational consulting
- strong cash generation and low leverage
- consistent dividend policy enhancing compounding
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin9.39%
P/E Ratio13.0
ROE14.30%
ROA5.96%
Debt/Equity28.11
P/B Ratio1.7
Op. Cash Flow$373.3M
Free Cash Flow$291.4M
Industry P/E29.5
Technical Analysis
TrendNeutral
RSI51.4
Support$60.99
Resistance$68.76
MA 20$66.14
MA 50$64.18
MA 200$67.23
MACDBearish
VolumeStable
Fear & Greed Index89.61
Valuation
Fair Value$107.10
Target Price$75.50
Upside/Downside14.95%
GradeUndervalued
TypeBlend
Dividend Yield3.35%
Risk Assessment
Beta0.77
Volatility28.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.